The following write-up was copied from Cannabis Pr
Post# of 85492
Knowledge to Profit
By Dr. Michael Dor
Cannabis legalization is an incredibly disruptive force.
As a Senior Medical Advisor at the Israeli Ministry of Health's Medical Cannabis Unit, I get to see much of this disruption first hand. And as an Advisory Board Member for the National Institute of Cannabis Investors, you'll be hearing from me about some of the incredible opportunities in cannabis science driving this disruption.
Ending prohibition will ultimately legitimize hundreds of billions of black market marijuana sales. And bringing these sales into the legal light means revenues - and profits - for cannabis entrepreneurs, investors, and businesses.
But the industry that is rapidly emerging will do far more than shift these revenues from one set of pockets to the other. It will create entirely new markets on the back of even larger, far more established industries.
This eruption of opportunity onto a field with such a large, pre-existing market has resulted in a massive acceleration of cannabis research and product development during the last few years. Fueling this acceleration is the number of countries and companies promoting or sponsoring research into new medicinal and recreational cannabis products.
This list grows daily, and understanding how the compounds found in cannabis work together lies at the heart of much of this research.